express gazette logo
The Express Gazette
Tuesday, September 22, 2026

Anthropic Delays IPO Amidst AI Safety Concerns and Internal Warnings

The AI company, valued at $2 trillion, pushes its stock market debut back to November following whistleblower concerns about rapid AI development and potential risks.

US Politics 2 hours ago
Anthropic Delays IPO Amidst AI Safety Concerns and Internal Warnings

Anthropic, the developer of the AI model Claude, is reportedly delaying its initial public offering (IPO) until November, a shift from earlier expectations of an October listing. This decision comes amid growing internal and external warnings about the pace of artificial intelligence development and its potential risks.

The potential delay, which could extend even further depending on market conditions and the outcome of U.S. midterm elections, is linked to increasing concerns that AI systems are advancing too rapidly, potentially becoming uncontrollable. These fears have been amplified by former Anthropic researcher Jacob Coxon, who recently resigned and issued stark warnings about the industry's trajectory.

Coxon's comments, which gained significant online traction, highlighted the rapid development of increasingly powerful AI systems by companies like Anthropic and OpenAI. He expressed concerns that these systems could pose an existential threat to humanity if not adequately controlled. These warnings resonate with Anthropic's own CEO, Dario Amodei, who has publicly called for a slowdown in the development of advanced AI models to allow safety measures to keep pace.

IMAGE2

Anthropic co-founder Jack Clark has echoed these sentiments, advocating for common safety standards and independent scrutiny within the AI industry. He has pointed to instances where AI systems have behaved in unexpected ways, suggesting a need for proactive measures before risks escalate.

These concerns are not purely theoretical. Anthropic has reported blocking several attempts by users to employ its AI systems for research that could potentially be used to develop biological weapons. The company stated it could not always determine the intent behind such research requests, adding to the debate about the misuse of advanced AI.

IMAGE7

Adding a political dimension to the debate, former President Donald Trump has strongly opposed calls for AI development delays and increased regulation. Trump asserted that his leadership would ensure AI's safe use in the United States, attributing this to his own


Sources